David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Brookdale Senior Living
BKD
$2.89B
| $16.4M | 0.02% |
2,487,210
+527,121
| +27% | +$3.87M |
|
|
AJRD
802
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $16.4M | 0.02% |
460,397
+81,940
| +22% | +$3.02M |
|
803
Portland General Electric
POR
$5.85B
| $16.3M | 0.02% |
315,052
-362,490
| -54% | -$17.7M |
|
804
Inspire Medical Systems
INSP
$1.78B
| $16.3M | 0.02% |
286,976
+227,438
| +382% | +$12.3M |
|
805
Glaukos
GKOS
$11B
| $16.2M | 0.02% |
206,870
+111,932
| +118% | +$7.47M |
|
806
CALL
RH
RH
$2.71B
| $16.2M | 0.02% |
157,100
-11,700
| -7% | -$1.59M |
|
807
CALL
Roku
ROKU
$23.5B
| $16.1M | 0.02% |
250,000
+140,000
| +127% | +$7.49M |
|
808
PUT
Workday
WDAY
$49.2B
| $16.1M | 0.02% |
83,500
+38,500
| +86% | +$7M |
|
809
PUT
Bread Financial
BFH
$4.04B
| $16.1M | 0.02% |
115,151
-22,303
| -16% | -$3.04M |
|
810
Acco Brands
ACCO
$387M
| $16.1M | 0.02% |
1,875,701
+29,189
| +2% | +$255K |
|
811
C.H. Robinson
CHRW
$16.7B
| $16.1M | 0.02% |
184,527
-88,342
| -32% | -$7.76M |
|
|
DISH
812
DELISTED
DISH Network Corp.
DISH
| $16M | 0.02% |
505,850
-12,643
| -2% | -$387K |
|
813
CALL
Allstate
ALL
$65.8B
| $16M | 0.02% |
169,800
+161,700
| +1,996% | +$14.6M |
|
814
CALL
Valero Energy
VLO
$99.6B
| $15.9M | 0.02% |
187,400
-5,500
| -3% | -$454K |
|
815
Benchmark Electronics
BHE
$2.58B
| $15.9M | 0.02% |
605,546
+20,992
| +4% | +$538K |
|
816
Leidos
LDOS
$17.4B
| $15.8M | 0.02% |
247,183
-19,439
| -7% | -$1.17M |
|
817
PUT
New Oriental
EDU
$8.97B
| $15.8M | 0.02% |
175,400
| – | – |
|
818
CALL
Shopify
SHOP
$193B
| $15.8M | 0.02% |
763,000
-419,000
| -35% | -$7.4M |
|
819
Gildan
GIL
$10.2B
| $15.8M | 0.02% |
437,700
-83,241
| -16% | -$2.85M |
|
820
SPX Corp
SPXC
$10.1B
| $15.7M | 0.02% |
452,687
-116,712
| -20% | -$3.79M |
|
821
Strategy Inc
MSTR
$48.7B
| $15.7M | 0.02% |
1,089,300
-956,640
| -47% | -$13.2M |
|
|
BID
822
DELISTED
Sotheby's
BID
| $15.7M | 0.02% |
416,249
-38,559
| -8% | -$1.55M |
|
823
PUT
Teva Pharmaceuticals
TEVA
$43B
| $15.7M | 0.02% |
1,000,700
-2,576,300
| -72% | -$45.4M |
|
824
Bright Horizons
BFAM
$3.6B
| $15.7M | 0.02% |
123,374
+42,801
| +53% | +$5.1M |
|
825
Repligen
RGEN
$10.2B
| $15.6M | 0.02% |
263,971
-2,659
| -1% | -$153K |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.